Showing results (1-10 of 21) with videos related to
Sort By:
Pageof 3
Thorax|May 1, 1989
Discrete pleural masses without effusion in a young man: an unusual presentation of tuberculosisS B Blunt, M G HarriesMovement Disorders : Official Journal of the Movement Disorder Society|November 1, 1996
Foot dystonia and lumbar canal stenosisS B Blunt, P G Richards, N KhalilThe European Journal of Neuroscience|January 6, 1999
Growth/differentiation factor 5 and glial cell line-derived neurotrophic factor enhance survival and function of dopaminergic grafts in a rat model of Parkinson's diseaseA M Sullivan, J Pohl, S B BluntMovement Disorders : Official Journal of the Movement Disorder Society|April 1, 1993
Suppressive effect of L-dopa on dopamine cells remaining in the ventral tegmental area of rats previously exposed to the neurotoxin 6-hydroxydopamineS B Blunt, P Jenner, C D MarsdenBrain Research|June 12, 1992
Autoradiographic study of striatal D1 and D2 dopamine receptors in 6-OHDA-lesioned rats receiving foetal ventral mesencephalic grafts and chronic treatment with L-dopa and carbidopaS B Blunt, P Jenner, C D MarsdenAge and Ageing|February 26, 2000
Measuring symptom change in patients with Parkinson's diseaseJ E Harrison, S Preston, S B BluntExperimental Brain Research|January 1, 1992
Motor function, graft survival and gliosis in rats with 6-OHDA lesions and foetal ventral mesencephalic grafts chronically treated with L-dopa and carbidopaS B Blunt, P Jenner, C D MarsdenNeuroscience|January 1, 1991
The effect of L-dopa and carbidopa treatment on the survival of rat fetal dopamine grafts assessed by tyrosine hydroxylase immunohistochemistry and [3H]mazindol autoradiographyS B Blunt, P Jenner, C D MarsdenBrain Research|November 14, 1998
Effects of pergolide treatment on in vivo hydroxyl free radical formation during infusion of 6-hydroxydopamine in rat striatumJ Opacka-Juffry, A W Wilson, S B BluntMovement Disorders : Official Journal of the Movement Disorder Society|June 8, 2001
Chronic L-DOPA administration is not toxic to the remaining dopaminergic nigrostriatal neurons, but instead may promote their functional recovery, in rats with partial 6-OHDA or FeCl(3) nigrostriatal lesionsK P Datla, S B Blunt, D T DexterPageof 3